Zevra Therapeutics
Price & Volume
Stats
See more52W Range | $8.01-$15.03 |
Market Cap | $655.5M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $136M |
Revenue Growth (YoY) | 53.3% |
Gross Profit (12 Mos) | $129.8M |
Diluted EPS | $0.93 |
News
See moreYahoo Finance • 2 months ago
Zevra Therapeutics, Inc. GAAP EPS of $0.14 beats by $0.03, revenue of $39.7M beats by $5.82M
Yahoo Finance • 2 months ago
Top profitable small caps trading at bargain P/E multiples during Q2 earnings
Yahoo Finance • 2 months ago
Zevra plunges on EU snub for rare disease therapy
Yahoo Finance • 3 months ago
As U.S. profit margins near record highs, these small-cap stocks lead on profitability
About
CEO | Mr. Neil F. McFarlane |
CFO | Mr. Justin A. Renz CPA, MBA |
Address | 101 Federal Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |